Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation

समान संसाधन

• Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
  द्वारा: de Vlam, K, और अन्य
  प्रकाशित: (2022)
• Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
  द्वारा: de Vlam, K, और अन्य
  प्रकाशित: (2018)
• Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
  द्वारा: Ogdie, A, और अन्य
  प्रकाशित: (2018)
• Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
  द्वारा: de Vlam, K, और अन्य
  प्रकाशित: (2021)
• Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
  द्वारा: Taylor, PC, और अन्य
  प्रकाशित: (2020)